Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Sekseverschillen in ernstige bijwerkingen van immuuntherapie, targeted therapie of chemotherapie
mei 2022 | Immuuntherapie, Leukemie, Longoncologie, Maag-darm-leveroncologie